Vaccine Distribution Challenges
Millions of vaccine doses remain unused due to distribution bottlenecks, raising concerns about ensuring second doses are available for those who received their first shot. The government is ramping up production through the Defense Production Act, aiming for an additional 200 million doses from Pfizer and Moderna. However, the complexity of manufacturing mRNA vaccines means that simply opening new facilities won't solve the problem quickly.In this clip
From this podcast
Chasing Life
Biden’s New Covid Team
Related Questions